Sun Pharmaceutical Industries has lined up 11 banks, including State Bank of India (SBI), to finance its $11.75 billion ...

The country’s largest lender, State Bank of India (SBI), and 10 other global banks, have combined forces to finance one of ...

India's dealmaking landscape in the April-June quarter was dominated by a handful of blockbuster transactions, with Sun ...

We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Organon & Co. (NYSE:OGN) is one of the ...

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced the completion of a global licensing agreement ...

Sun Pharma expects strong cash flows from the combined business to support debt reduction, innovation investments and growth across specialty medicines, women’s health and global markets.

The company has submitted a Form DEFM14A to the SEC, indicating an upcoming shareholder vote. This form gives shareholders all the information they need to develop an informed vote. Read on to learn ...

In the Asian market today, Japans Nikkei extended its climb past the 68,000 mark, offering support for Indian equities in ...

The deal values Crinetics at $85 per share in cash, representing a potential upside of about 100% from the stock’s closing ...

Organon, a global healthcare company, announced the completion of a global licensing agreement with Sebela Pharmaceuticals, granting Organon exclusive rights to Miudella, a hormone-free, copper ...